Arax Advisory Partners’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.34K Buy
1,201
+733
+157% +$4.69K ﹤0.01% 4526
2026
Q1
$3.41K Buy
468
+314
+204% +$2.84K ﹤0.01% 2950
2025
Q4
$1.48K Sell
154
-8,951
-98% -$92.6K ﹤0.01% 3370
2025
Q3
$111K Buy
9,105
+8,953
+5,890% +$94K ﹤0.01% 1500
2025
Q2
$1.22K Sell
152
-2,281
-94% -$16K ﹤0.01% 2718
2025
Q1
$17.7K Buy
+2,433
New +$17.7K ﹤0.01% 1354
2024
Q4
Sell
-532
Closed -$3.92K 2641
2024
Q3
$3.92K Hold
532
﹤0.01% 1818
2024
Q2
$5.61K Buy
+532
New +$6.74K ﹤0.01% 1543

Other funds holding NUS

Arax Advisory Partners's NUS Position: Q2 2026 in Review

Arax Advisory Partners increased its Nu Skin (NUS) stake by 157% in Q2 2026, buying an estimated $4.69K and bringing the position to 1,201 shares worth $6.34K. The position accounts for ﹤0.01% of the portfolio, ranked #4526.

Arax Advisory Partners first reported a position in NUS in Q2 2024 and has held it in 8 quarters since. The position peaked at $111K in Q3 2025. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Arax Advisory Partners held 1,201 shares of Nu Skin worth $6.34K as of Q2 2026.
  • Arax Advisory Partners bought 733 Nu Skin shares in Q2 2026, an estimated $4.69K.
  • Nu Skin made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4526 holding.
  • Arax Advisory Partners first reported a position in Nu Skin in Q2 2024 and has held it in 8 quarters since.
  • Arax Advisory Partners's Nu Skin position peaked at $111K in Q3 2025.
  • 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.